QC
CRBU icon

Quadrature Capital’s Caribou Biosciences CRBU Stock Holding History

Quadrature Capital’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
88,979
+49,423
+125% +$97.7K ﹤0.01% 1409
2026
Q1 		$75.2K Sell
39,556
-119,761
-75% -$206K ﹤0.01% 1259
2025
Q4 		$253K Buy
+159,317
New +$334K ﹤0.01% 901
2025
Q3 		– Sell
-91,110
Closed -$114K – 1112
2025
Q2 		$114K Buy
+91,110
New +$89.6K ﹤0.01% 882

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Quadrature Capital's CRBU Position: Q2 2026 in Review

Quadrature Capital increased its Caribou Biosciences (CRBU) stake by 125% in Q2 2026, buying an estimated $97.7K and bringing the position to 88,979 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #1409.

Quadrature Capital first reported a position in CRBU in Q2 2025 and has held it in 4 quarters since. The position peaked at $253K in Q4 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Quadrature Capital held 88,979 shares of Caribou Biosciences worth $157K as of Q2 2026.
  • Quadrature Capital bought 49,423 Caribou Biosciences shares in Q2 2026, an estimated $97.7K.
  • Caribou Biosciences made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1409 holding.
  • Quadrature Capital first reported a position in Caribou Biosciences in Q2 2025 and has held it in 4 quarters since.
  • Quadrature Capital's Caribou Biosciences position peaked at $253K in Q4 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.